<?xml version="1.0" encoding="UTF-8"?>
<p class="p">DNA methylation in newborns from women who were given n-3 FA supplementation during late pregnancy has been evaluated in a few clinical trials [
 <xref rid="B91-ijms-20-02118" ref-type="bibr" class="xref">91</xref>]. DNA methylation changes following six-week supplementation with 3 g of n-3 FAs supplementation in 36 overweight and obese subjects showed that 308 CpG sites involved in inflammatory and immune response, type 2 diabetes, lipid metabolism, and cardiovascular signaling were differentially methylated after the intervention [
 <xref rid="B92-ijms-20-02118" ref-type="bibr" class="xref">92</xref>].
</p>
